World's Best Scientists 2026 revealed!
Award Badge
Neuroscience
Canada
2026
Award Badge
Medicine
Canada
2023

D-Index & Metrics

Medicine

D-Index
127
Citations
60762
World Ranking
2825
National Ranking
112

Neuroscience

D-Index
127
Citations
60263
World Ranking
308
National Ranking
8

Douglas L. Arnold publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Douglas L. Arnold sits on this spectrum.

38–47 publications: 18 scientists 48–57 publications: 79 scientists 58–67 publications: 193 scientists 68–77 publications: 323 scientists 78–87 publications: 406 scientists 88–97 publications: 452 scientists 98–107 publications: 539 scientists 108–117 publications: 505 scientists 118–127 publications: 522 scientists 128–137 publications: 469 scientists 138–147 publications: 456 scientists 148–157 publications: 459 scientists 158–167 publications: 397 scientists 168–177 publications: 383 scientists 178–187 publications: 350 scientists 188–197 publications: 302 scientists 198–207 publications: 306 scientists 208–217 publications: 262 scientists 218–227 publications: 242 scientists 228–237 publications: 220 scientists 238–247 publications: 203 scientists 248–257 publications: 174 scientists 258–267 publications: 176 scientists 268–277 publications: 175 scientists 278–287 publications: 125 scientists 288–297 publications: 116 scientists 298–307 publications: 127 scientists 308–317 publications: 128 scientists 318–327 publications: 99 scientists 328–337 publications: 89 scientists 338–347 publications: 78 scientists 348–357 publications: 96 scientists 358–367 publications: 66 scientists 368–377 publications: 59 scientists 378–387 publications: 65 scientists 388–397 publications: 54 scientists 398–407 publications: 48 scientists 408–417 publications: 49 scientists 418–427 publications: 34 scientists 428–437 publications: 31 scientists 438–447 publications: 30 scientists 448–457 publications: 31 scientists 458–467 publications: 36 scientists 468–477 publications: 40 scientists 478–487 publications: 35 scientists 488–497 publications: 30 scientists 498–507 publications: 23 scientists 508–517 publications: 26 scientists 518–527 publications: 20 scientists 528–537 publications: 23 scientists 538–547 publications: 20 scientists 548–557 publications: 20 scientists 558–567 publications: 17 scientists 568–577 publications: 14 scientists 578–587 publications: 20 scientists 588–597 publications: 20 scientists 598–607 publications: 19 scientists 608–617 publications: 18 scientists 618–627 publications: 17 scientists 628–637 publications: 11 scientists 638–647 publications: 11 scientists 648–657 publications: 11 scientists 658–667 publications: 8 scientists 668–677 publications: 7 scientists 678–687 publications: 11 scientists 688–697 publications: 10 scientists 698–707 publications: 4 scientists 708–717 publications: 6 scientists 718–727 publications: 5 scientists 728–737 publications: 5 scientists 738–747 publications: 9 scientists 748–757 publications: 9 scientists 758–767 publications: 3 scientists 768–777 publications: 7 scientists 778–787 publications: 7 scientists 788–797 publications: 6 scientists 798–807 publications: 2 scientists 808–817 publications: 2 scientists 818–827 publications: 7 scientists 828–837 publications: 0 scientists 838–847 publications: 9 scientists 848–857 publications: 3 scientists 858–867 publications: 1 scientists 868–877 publications: 3 scientists 878–886 publications: 6 scientists 887+ publications: 100 scientists
38 publications 887+

This scientist: 777 publications — 98th percentile

98% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 887 publications or more.

Douglas L. Arnold D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Douglas L. Arnold sits on this spectrum.

30–31 D-Index: 42 scientists 32–33 D-Index: 172 scientists 34–35 D-Index: 296 scientists 36–37 D-Index: 435 scientists 38–39 D-Index: 459 scientists 40–41 D-Index: 456 scientists 42–43 D-Index: 467 scientists 44–45 D-Index: 478 scientists 46–47 D-Index: 512 scientists 48–49 D-Index: 435 scientists 50–51 D-Index: 425 scientists 52–53 D-Index: 418 scientists 54–55 D-Index: 392 scientists 56–57 D-Index: 357 scientists 58–59 D-Index: 334 scientists 60–61 D-Index: 328 scientists 62–63 D-Index: 260 scientists 64–65 D-Index: 278 scientists 66–67 D-Index: 239 scientists 68–69 D-Index: 250 scientists 70–71 D-Index: 210 scientists 72–73 D-Index: 200 scientists 74–75 D-Index: 189 scientists 76–77 D-Index: 170 scientists 78–79 D-Index: 146 scientists 80–81 D-Index: 113 scientists 82–83 D-Index: 126 scientists 84–85 D-Index: 100 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 99 scientists 90–91 D-Index: 84 scientists 92–93 D-Index: 85 scientists 94–95 D-Index: 72 scientists 96–97 D-Index: 76 scientists 98–99 D-Index: 45 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 43 scientists 104–105 D-Index: 32 scientists 106–107 D-Index: 45 scientists 108–109 D-Index: 50 scientists 110–111 D-Index: 32 scientists 112–113 D-Index: 39 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 27 scientists 120–121 D-Index: 19 scientists 122–123 D-Index: 23 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 16 scientists 128–129 D-Index: 24 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 21 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 14 scientists 138–139 D-Index: 15 scientists 140–141 D-Index: 10 scientists 142–143 D-Index: 10 scientists 144–145 D-Index: 13 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 8 scientists 150–151 D-Index: 6 scientists 152–153 D-Index: 6 scientists 154–155 D-Index: 7 scientists 156–157 D-Index: 7 scientists 158–159 D-Index: 10 scientists 160–161 D-Index: 4 scientists 162 D-Index: 8 scientists 163+ D-Index: 100 scientists
30 D-Index 163+

This scientist: 127 D-Index — 97th percentile

97% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 163 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Neuroscience in Canada Leader Award
  • 2025 - Research.com Neuroscience in Canada Leader Award
  • 2023 - Research.com Medicine in Canada Leader Award

Overview

Douglas L. Arnold is affiliated with the Montreal Neurological Institute and Hospital in Canada. Their research primarily focuses on Medicine with a significant emphasis on subfields such as Pathology and Forensic Medicine, Radiology, Nuclear Medicine and Imaging, Neurology, Oncology, and Rheumatology.

Their scholarly work extensively covers topics including Multiple Sclerosis Research Studies, Polyomavirus and related diseases, Chronic Lymphocytic Leukemia Research, Peripheral Neuropathies and Disorders, Rheumatoid Arthritis Research and Therapies, Chronic Myeloid Leukemia Treatments, and Radiomics and Machine Learning in Medical Imaging.

Douglas L. Arnold has published numerous articles in various scientific venues. Frequent publication venues include:

  • Neurology
  • Multiple Sclerosis Journal
  • Multiple Sclerosis and Related Disorders
  • arXiv (Cornell University)
  • Revue Neurologique

Their recent papers highlight ongoing research in neurological disorders, especially related to multiple sclerosis. Notable papers include:

  • Contribution of Relapse-Independent Progression vs Relapse-Associated Worsening to Overall Confirmed Disability Accumulation in Typical Relapsing Multiple Sclerosis in a Pooled Analysis of 2 Randomized Clinical Trials, 2020, JAMA Neurology
  • How patients with multiple sclerosis acquire disability, 2022, Brain
  • Identifying multiple sclerosis subtypes using unsupervised machine learning and MRI data, 2021, Nature Communications
  • Secondary Progressive Multiple Sclerosis, 2021, Neurology
  • Safety and efficacy of tolebrutinib, an oral brain-penetrant BTK inhibitor, in relapsing multiple sclerosis: a phase 2b, randomised, double-blind, placebo-controlled trial, 2021, The Lancet Neurology

The scientist collaborates frequently with other researchers in the field. Frequent co-authors include:

  • Amit Bar-Or
  • Ludwig Kappos
  • Xavier Montalbán
  • Sridar Narayanan
  • Bruce Cree

Best Publications

  • B-cell depletion with rituximab in relapsing-remitting multiple sclerosis.

    Stephen L. Hauser;Emmanuelle Waubant;Douglas L. Arnold;Timothy Vollmer

  • Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis.

    Stephen L. Hauser;Amit Bar-Or;Giancarlo Comi;Gavin Giovannoni

  • Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis

    Ralf Gold;Ludwig Kappos;Douglas L Arnold;Amit Bar-Or

  • Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis

    Xavier Montalban;Stephen L. Hauser;Ludwig Kappos;Douglas L. Arnold

  • Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial.

    Jeffrey A. Cohen;Alasdair J. Coles;Douglas L. Arnold;Christian Confavreux

  • Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: A randomised controlled phase 3 trial

    Alasdair J. Coles;Cary L. Twyman;Douglas L. Arnold;Jeffrey A. Cohen

  • Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

    Unknown

  • Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy.

    Preul Mc;Caramanos Z;Collins Dl;Villemure Jg

  • Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability.

    Nicola De Stefano;Sridar Narayanan;Gordon S. Francis;Rozie Arnaoutelis

  • Rituximab in relapsing-remitting multiple sclerosis: a 72-week, open-label, phase I trial.

    Amit Bar-Or;Peter A. J. Calabresi;Douglas Arnold;Clyde Markowitz

  • Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study.

    N De Stefano;P M Matthews;L Fu;S Narayanan

  • Imaging axonal damage of normal-appearing white matter in multiple sclerosis.

    L Fu;P M Matthews;N De Stefano;K J Worsley

  • Mesial temporal damage in temporal lobe epilepsy: a volumetric MRI study of the hippocampus, amygdala and parahippocampal region.

    N Bernasconi;A Bernasconi;Z Caramanos;S B Antel

  • Contribution of Relapse-Independent Progression vs Relapse-Associated Worsening to Overall Confirmed Disability Accumulation in Typical Relapsing Multiple Sclerosis in a Pooled Analysis of 2 Randomized Clinical Trials.

    Ludwig Kappos;Jerry S. Wolinsky;Gavin Giovannoni;Douglas L. Arnold

  • Metabolic recovery after exercise and the assessment of mitochondrial function in vivo in human skeletal muscle by means of 31P NMR.

    D. L. Arnold;P. M. Matthews;G. K. Radda

  • Reversible decreases in N-acetylaspartate after acute brain injury.

    Nicola De Stefano;Paul M. Matthews;Douglas L. Arnold;Douglas L. Arnold

  • How patients with multiple sclerosis acquire disability

    Unknown

  • Pegylated interferon beta-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study

    Peter A Calabresi;Bernd C Kieseier;Douglas L Arnold;Laura J Balcer

  • Review of automatic segmentation methods of multiple sclerosis white matter lesions on conventional magnetic resonance imaging.

    Daniel García-Lorenzo;Simon J. Francis;Sridar Narayanan;Douglas L. Arnold

  • Exploring uncertainty measures in deep networks for Multiple sclerosis lesion detection and segmentation.

    Tanya Nair;Doina Precup;Douglas L. Arnold;Tal Arbel

  • Evidence for adaptive functional changes in the cerebral cortex with axonal injury from multiple sclerosis.

    H Reddy;S Narayanan;R Arnoutelis;M Jenkinson

  • Chemical pathology of acute demyelinating lesions and its correlation with disability

    N De Stefano;P M Matthews;P M Matthews;J P Antel;M Preul

Frequent Co-Authors

Amit Bar-Or
Amit Bar-Or University of Pennsylvania
Sridar Narayanan
Sridar Narayanan Montreal Neurological Institute and Hospital
Krzysztof Selmaj
Krzysztof Selmaj University of Warmia and Mazury in Olsztyn
Eva Havrdova
Eva Havrdova Charles University
Brenda Banwell
Brenda Banwell Children's Hospital of Philadelphia
Ludwig Kappos
Ludwig Kappos University Hospital of Basel
Gavin Giovannoni
Gavin Giovannoni Queen Mary University of London
Paul M. Matthews
Paul M. Matthews Imperial College London
D. Louis Collins
D. Louis Collins McGill University
Hans-Peter Hartung
Hans-Peter Hartung Heinrich Heine University Düsseldorf

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying neuroscience in the USA opens diverse opportunities in healthcare, therapy, and research. Many students interested in neuroscience also consider related fields like counseling, psychology, and family therapy for specialized career pathways. Pursuing an advanced degree online makes these options more accessible and affordable, especially for those balancing work and study.

For those passionate about counseling, enrolling in programs at cacrep accredited schools ensures high educational and ethical standards. If cost is a major concern, many affordable online masters counseling programs offer strong value without compromising quality. For individuals interested in supporting couples and families, a marriage and family therapist degree is a worthwhile path you can pursue online.

Understanding the financial investment is crucial. Prospective students can research how much is a master's degree in psychology to make informed decisions that align with their career goals and budget. Exploring these related online degrees expands career prospects for neuroscience students by blending scientific understanding with practical, people-centered expertise.

Best Scientists Citing Douglas L. Arnold

Trending Scientists

Recently Published Articles